Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

7.1%

2 terminated/withdrawn out of 28 trials

Success Rate

88.2%

+1.7% vs industry average

Late-Stage Pipeline

36%

10 trials in Phase 3/4

Results Transparency

33%

5 of 15 completed trials have results

Key Signals

5 recruiting5 with results

Enrollment Performance

Analytics

N/A

10(43.5%)

Phase 3

5(21.7%)

Phase 4

5(21.7%)

Phase 2

3(13.0%)

23Total

N/A(10)

Phase 3(5)

Phase 4(5)

Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials

NCT04076735Not ApplicableRecruiting

DIFFIR - Geriatric Distal Femur Fixation Versus Replacement

Role: collaborator

NCT06028126Not ApplicableCompleted

Superficial Parasternal Intercostal Plane Block in Cardiac Surgery Trial

Role: collaborator

NCT06396416Phase 4Recruiting

Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2

Role: collaborator

NCT06410508Not ApplicableRecruiting

Evaluation of a Brief Intervention to Improve Engagement in Early Intervention Services for Psychosis

Role: collaborator

NCT07392424Not ApplicableNot Yet Recruiting

BreastCancerPEP: A Six-Month Online Empowerment Program to Improve Mental and Physical Health in Women With Breast Cancer

Role: collaborator

NCT05023785Not ApplicableRecruiting

The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial

Role: collaborator

NCT00136435Phase 2Completed

A Study in Adults With Untreated Acute Lymphoblastic Leukemia

Role: collaborator

NCT05033301Not ApplicableRecruiting

Evaluating the Effectiveness of the Nurse Ned Clinic

Role: collaborator

NCT04732689Completed

Intraoperative Hemodynamic Management and Postoperative Outcomes in Liver Transplantation

Role: collaborator

NCT04362085Phase 3Completed

Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care

Role: collaborator

NCT03506815Phase 3Completed

Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines

Role: collaborator

NCT05867355Unknown

Surgically Treated Displaced Mid-diaphyseal Clavicle Fractures

Role: collaborator

NCT03660085Not ApplicableCompleted

Prostate Cancer - Patient Empowerment Program

Role: collaborator

NCT00519714Phase 2Completed

A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA)

Role: collaborator

NCT00794573Phase 3Completed

Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial

Role: collaborator

NCT02206880Completed

The Delirium-CS Canada Study

Role: collaborator

NCT01824654Not ApplicableCompleted

Enhanced Guidance for Endovascular Repair of Abdominal Aortic Aneurysm

Role: collaborator

NCT01643746Not ApplicableWithdrawn

Evaluation of Luminal Expansion Following Stenting of Femoro-popliteal Occlusive Disease

Role: collaborator

NCT03460054Unknown

The Canadian Glomerulonephritis Registry and Translational Research Initiative

Role: collaborator

NCT02116036Phase 4Completed

Rivaroxaban for Antiphospholipid Antibody Syndrome

Role: collaborator